Fairmount Healthcare Fund Ii L.p. - Net Worth and Insider Trading
Fairmount Healthcare Fund Ii L.p. Net Worth
The estimated net worth of Fairmount Healthcare Fund Ii L.p. is at least $28 Million dollars as of 2024-09-20. Fairmount Healthcare Fund Ii L.p. is the Director of Zenas BioPharma Inc and owns about 1,604,891 shares of Zenas BioPharma Inc (ZBIO) stock worth over $28 Million. Details can be seen in Fairmount Healthcare Fund Ii L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fairmount Healthcare Fund Ii L.p. has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fairmount Healthcare Fund Ii L.p.
Fairmount Healthcare Fund Ii L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fairmount Healthcare Fund Ii L.p. owns 3 companies in total, including Viridian Therapeutics Inc (VRDN) , Spyre Therapeutics Inc (SYRE) , and Apogee Therapeutics Inc (APGE) .
Insider Ownership Summary of Fairmount Healthcare Fund Ii L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VRDN | Viridian Therapeutics Inc | 2020-10-27 | director & other: See Remarks |
SYRE | Spyre Therapeutics Inc | 2023-06-22 | director & 10 percent owner |
APGE | Apogee Therapeutics Inc | 2023-07-13 | director |
Fairmount Healthcare Fund Ii L.p. Latest Holdings Summary
Fairmount Healthcare Fund Ii L.p. currently owns a total of 1 stock. Fairmount Healthcare Fund Ii L.p. owns 1,604,891 shares of Zenas BioPharma Inc (ZBIO) as of September 16, 2024, with a value of $28 Million.
Latest Holdings of Fairmount Healthcare Fund Ii L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZBIO | Zenas BioPharma Inc | 2024-09-16 | 1,604,891 | 17.71 | 28,422,620 |
Holding Weightings of Fairmount Healthcare Fund Ii L.p.
Fairmount Healthcare Fund Ii L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Fairmount Healthcare Fund Ii L.p. has made a total of 2 transactions in Zenas BioPharma Inc (ZBIO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Zenas BioPharma Inc is the acquisition of 300,000 shares on September 16, 2024, which cost Fairmount Healthcare Fund Ii L.p. around $5 Million.
Insider Trading History of Fairmount Healthcare Fund Ii L.p.
- 1
Fairmount Healthcare Fund Ii L.p. Trading Performance
Fairmount Healthcare Fund Ii L.p. Ownership Network
Fairmount Healthcare Fund Ii L.p. Owned Company Details
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Fairmount Healthcare Fund Ii L.p. is the director & other: See Remarks of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc , director & other: See Remarks Fairmount Healthcare Fund Gp Llc , and director & President and CEO Stephen F. Mahoney .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Fairmount Healthcare Fund Ii L.p. made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 9,796 shares made by Lara Meisner , a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 1,600,000 shares, with a net purchase of 1,600,000 shares. During the past 18 months, 9,796 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,080,190 shares were bought by its insiders, resulting in a net purchase of 2,070,394 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
Fairmount Healthcare Fund Ii L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Fairmount Healthcare Fund Ii L.p.. You might contact Fairmount Healthcare Fund Ii L.p. via mailing address: 200 Barr Harbor Drive, Suite 400, West Conshohocken Pa 19428.